에 의해 게시 Skyscape Medpresso Inc
1. * More than 500 revisions to existing monographs (affecting 60% of the existing monographs) have been accomplished to update information on stability, compatibility, and safety (e.g., Food and Drug Administration [FDA] MedWatch alerts) and to provide more specific referencing of manufacturer information and enhancements to the more than 24,100 compatibility pairs contained in ASHP® Injectable Drug Information™ 2024.
2. Because information from pharmaceutical manufacturers had not been uniquely cited until the 18th edition, the number of unique references supporting ASHP® Injectable Drug Information™ 2024 information actually greatly exceeds this number.
3. * While primary, peer-reviewed literature remains a major source of compatibility and stability information, ongoing efforts are underway to provide increased specificity of references to the pharmaceutics research of drug manufacturers.
4. ASHP® Injectable Drug Information™ 2024 content is interactive, mobile, and updated quarterly.
5. Other relevant information and pertinent study details supplied by corresponding authors of the published literature also have been incorporated when available.
6. * The information cited throughout the text has been compiled from 3603 references, including 195 new to this edition.
7. Please purchase a yearly auto-renewing subscription to receive content access and available updates.
8. For over 50 years American Society of Health-System Pharmacists is the most comprehensive reference on injectable drug data.
9. * 18 new monographs, bringing the total in this edition to 417 monographs on parenteral drugs available in the United States and in other countries.
10. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.
11. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”.
호환되는 PC 앱 또는 대안 확인
앱 | 다운로드 | 평점 | 개발자 |
---|---|---|---|
Handbook on Injectable Drugs | 앱 또는 대안 다운로드 ↲ | 11 4.64
|
Skyscape Medpresso Inc |
또는 아래 가이드를 따라 PC에서 사용하십시오. :
PC 버전 선택:
소프트웨어 설치 요구 사항:
직접 다운로드 가능합니다. 아래 다운로드 :
설치 한 에뮬레이터 애플리케이션을 열고 검색 창을 찾으십시오. 일단 찾았 으면 Handbook on Injectable Drugs 검색 막대에서 검색을 누릅니다. 클릭 Handbook on Injectable Drugs응용 프로그램 아이콘. 의 창 Handbook on Injectable Drugs Play 스토어 또는 앱 스토어의 스토어가 열리면 에뮬레이터 애플리케이션에 스토어가 표시됩니다. Install 버튼을 누르면 iPhone 또는 Android 기기 에서처럼 애플리케이션이 다운로드되기 시작합니다. 이제 우리는 모두 끝났습니다.
"모든 앱 "아이콘이 표시됩니다.
클릭하면 설치된 모든 응용 프로그램이 포함 된 페이지로 이동합니다.
당신은 아이콘을 클릭하십시오. 그것을 클릭하고 응용 프로그램 사용을 시작하십시오.
다운로드 Handbook on Injectable Drugs Mac OS의 경우 (Apple)
다운로드 | 개발자 | 리뷰 | 평점 |
---|---|---|---|
Free Mac OS의 경우 | Skyscape Medpresso Inc | 11 | 4.64 |
PC를 설정하고 Windows 11에서 Handbook on Injectable Drugs 앱을 다운로드하는 단계:
“Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content. For over 50 years American Society of Health-System Pharmacists is the most comprehensive reference on injectable drug data. 2024 edition features 400+ monographs on parenteral drugs, 24,500+ compatibility pairs, 3,700+ unique references 5-Star Rating from Doody's Review Service and Doody's Core Titles List Selection ASHP® Injectable Drug Information™ 2024 content is interactive, mobile, and updated quarterly. Includes monographs to Extended Stability for Parenteral Drugs, forming a single, comprehensive resource on injectable drug information.. Key Features * Quick data search for 358 drugs * 417 monographs on parenteral drugs available in the United States and in other countries * Monographs cross-referenced with American Society of Health-System Pharmacists (AHFS) Drug Information through AHFS classification numbers * More than 500 revisions to existing monographs (affecting 60% of the existing monographs) have been accomplished to update information on stability, compatibility, and safety (e.g., Food and Drug Administration [FDA] MedWatch alerts) and to provide more specific referencing of manufacturer information and enhancements to the more than 24,100 compatibility pairs contained in ASHP® Injectable Drug Information™ 2024. * How to prepare, store and administer drugs * Info accumulated from 3,603 references * Drugs listed alphabetically by generic name for efficient searching, with brand names listed WHAT'S NEW ASHP® Injectable Drug Information™ 2024 includes * 18 new monographs, bringing the total in this edition to 417 monographs on parenteral drugs available in the United States and in other countries. * More than 500 revisions to existing monographs (affecting nearly 60% of the existing monographs) have been accomplished to update information on stability, compatibility, and safety (e.g., Food and Drug Administration [FDA] MedWatch alerts) and to provide more specific referencing of manufacturer information and other enhancements to the more than 24,100 compatibility pairs * The information cited throughout the text has been compiled from 3603 references, including 195 new to this edition. Because information from pharmaceutical manufacturers had not been uniquely cited until the 18th edition, the number of unique references supporting ASHP® Injectable Drug Information™ 2024 information actually greatly exceeds this number. * While primary, peer-reviewed literature remains a major source of compatibility and stability information, ongoing efforts are underway to provide increased specificity of references to the pharmaceutics research of drug manufacturers. Other relevant information and pertinent study details supplied by corresponding authors of the published literature also have been incorporated when available. Content licensed from printed edition ISBN 10: 1585286834 Content licensed from printed edition ISBN 13: 9781585286836 SUBSCRIPTION : Please purchase a yearly auto-renewing subscription to receive content access and available updates. Yearly auto-renewing payments- $49.99 Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable. If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-30000 Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx Editor(s): ASHP Publisher: American Society of Health-System Pharmacists
sTrack Nursing Skills Log
Skyscape Medical Library
Evidence Based Medicine Guide
Snap Word
nTrack Clinical Log
질병관리청 COOV(코로나19 전자예방접종증명서)
The건강보험
닥터나우 - 원격진료부터 약 배송까지
생활치료센터 비대면진료서비스
올라케어 - 아플땐 병원 바쁠땐 올라케어
바이코로나(Bye COVID-19)
마미톡 - 임신부터 출산, 육아까지
280days : 부부가 공유하는 "임신 기록/일기"
BabyTime (아기 육아 기록&분석, 베이비타임)
베이비빌리 - 태교, 임신, 출산, 육아 정보
세이베베 - 임신, 출산, 육아
열나요 - Fever Coach
서울대학교병원
메디피움
순산해요